Literature DB >> 7898615

Morphogenesis of amyloid plaques in 87V murine scrapie.

M Jeffrey1, C M Goodsir, M E Bruce, P A McBride, C Farquhar.   

Abstract

Amyloid plaques of scrapie-infected mouse brains are composed of fibrillar forms of a host coded, cell surface sialoglycoprotein called PrP (prion protein). Serial ultrastructural immunogold staining was performed on plaques identified by light microscopic immunocytochemistry of brains of VM mice infected with the 87V strain of scrapie. Classical plaques, of a kuru-type morphology, were composed of a central core of bundles of amyloid fibrils. Amyloid fibrils of classical plaques were immunoreactive for PrP. In addition, PrP was also found at the plaque periphery, in the absence of fibrils, at the plasmalemma of cell processes and in the associated extracellular spaces. Frequent microglial cells and occasional astrocytes contained PrP within lysosomes. Other plaques with few or no recognizable amyloid fibrils were frequent and were termed primitive plaques. PrP could be demonstrated in a non-fibrillar form at the plasmalemma and in the extracellular spaces between neurites of such plaques. Many primitive plaques showed little or no sub-cellular pathology associated with the PrP accumulation. PrP was closely associated with the plasmalemma of occasional dendrites passing towards the centre of primitive plaques. These results suggest that plaques are formed around one or more PrP releasing dendrites. PrP accumulates in the extracellular spaces adjacent to such processes prior to its spontaneous aggregation into fibrils. Lysosomal accumulation of PrP in microglia and astrocytes located at the periphery of plaques suggest that these cells are involved in the phagocytosis of excess or abnormal PrP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7898615     DOI: 10.1111/j.1365-2990.1994.tb01007.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  14 in total

1.  Subcellular localization of disease-associated prion protein in the human brain.

Authors:  Gábor G Kovács; Matthias Preusser; Michaela Strohschneider; Herbert Budka
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

Review 2.  Microglia in prion diseases.

Authors:  Adriano Aguzzi; Caihong Zhu
Journal:  J Clin Invest       Date:  2017-07-17       Impact factor: 14.808

3.  Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins.

Authors:  C K Combs; D E Johnson; S B Cannady; T M Lehman; G E Landreth
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

4.  Non-amyloid and amyloid prion protein deposits in prion-infected mice differ in blockage of interstitial brain fluid.

Authors:  A Rangel; B Race; J Striebel; B Chesebro
Journal:  Neuropathol Appl Neurobiol       Date:  2013-04       Impact factor: 8.090

5.  Different Molecular Mechanisms Mediate Direct or Glia-Dependent Prion Protein Fragment 90-231 Neurotoxic Effects in Cerebellar Granule Neurons.

Authors:  Stefano Thellung; Elena Gatta; Francesca Pellistri; Valentina Villa; Alessandro Corsaro; Mario Nizzari; Mauro Robello; Tullio Florio
Journal:  Neurotox Res       Date:  2017-05-25       Impact factor: 3.911

6.  An In Vivo 11C-(R)-PK11195 PET and In Vitro Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease.

Authors:  Leonardo Iaccarino; Rosa Maria Moresco; Luca Presotto; Orso Bugiani; Sandro Iannaccone; Giorgio Giaccone; Fabrizio Tagliavini; Daniela Perani
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

Review 7.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

8.  Stability of murine scrapie strain 87V after passage in sheep and comparison with the CH1641 ovine strain.

Authors:  Lorenzo González; Francesca Chianini; Nora Hunter; Scott Hamilton; Louise Gibbard; Stuart Martin; Mark P Dagleish; Sílvia Sisó; Samantha L Eaton; Angela Chong; Lynne Algar; Martin Jeffrey
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

9.  Pathology of SSLOW, a transmissible and fatal synthetic prion protein disorder, and comparison with naturally occurring classical transmissible spongiform encephalopathies.

Authors:  M Jeffrey; G McGovern; N Makarava; L González; Y-S Kim; R G Rohwer; I V Baskakov
Journal:  Neuropathol Appl Neurobiol       Date:  2014-04       Impact factor: 8.090

10.  Mechanism of PrP-amyloid formation in mice without transmissible spongiform encephalopathy.

Authors:  Martin Jeffrey; Gillian McGovern; Emily V Chambers; Declan King; Lorenzo González; Jean C Manson; Bernardino Ghetti; Pedro Piccardo; Rona M Barron
Journal:  Brain Pathol       Date:  2011-07-25       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.